Intellectual Property Transactions
Horn & Co. has particular expertise in life sciences, medical devices, internet, software, telecommunications and cleantech. The firm was selected by IAM Magazine as one of the top 6 recommended Israeli firms in the field of licensing with 3 of our partners designated as leading individuals. With a thorough understanding of the specific complexities and needs of technology-based, long-haul development companies, the firm represents clients in all aspects of strategic transactions.
Recent technology transactions include:
o License, license option, joint development and prototype agreements with companies including Pfizer, Edwards, Medtronic, Teva, Yahoo Japan, iCO Therapeutics, Bosch, WAKO, InGeneron, Cleveland Clinic, GE Medical, Smith and Nephew, and Duoyuan.
o Data license agreements with leading healthcare providers, insurers and companies.
o Representation of Interwise Ltd. and other software companies in their in and out licensing, co development, procurement and related matters (transactions involving Fortune 500 Companies and many Israeli companies since 2004);
o Licensing transactions with technology transfer companies of academic institutions and hospitals in Israel and outside of Israel.
o Clinical trial agreements and CRO agreements with dozens of medical centers worldwide;
o Manufacturing agreements;
o Advice to clients about procurement, distribution agreements, and ownership of intellectual property with entities including Pfizer, Memorial Sloan Kettering Cancer Center, and several medical centers in Israel and abroad; and
o Advice regarding multinational consortium agreements.
Horn & Co. was chosen as the Israeli representative to Biolegis, the European network of leading law firms specializing in biotechnology and medical devices, in which one firm from each country is represented (BIOLEGIS). Yuval Horn is former co-Chair and current member of the SAB of the International Bar Association (IBA) Technology Law Committee.